Hinge Health Inc. (NYSE:HNGE – Get Free Report) major shareholder Insight Holdings Group, Llc sold 1,466,667 shares of the stock in a transaction on Monday, June 29th. The shares were sold at an average price of $82.83, for a total value of $121,484,027.61. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Insight Holdings Group, Llc also recently made the following trade(s):
- On Thursday, June 25th, Insight Holdings Group, Llc sold 530,982 shares of Hinge Health stock. The stock was sold at an average price of $71.82, for a total value of $38,135,127.24.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The stock was sold at an average price of $71.67, for a total value of $10,199,429.37.
- On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The shares were sold at an average price of $71.15, for a total value of $27,813,744.55.
- On Tuesday, June 23rd, Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock. The shares were sold at an average price of $70.21, for a total value of $7,897,010.17.
- On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total transaction of $15,921,109.05.
- On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The shares were sold at an average price of $70.36, for a total transaction of $4,614,279.16.
Hinge Health Stock Performance
NYSE:HNGE opened at $84.15 on Friday. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $86.66. The stock has a market capitalization of $6.51 billion, a P/E ratio of -6.82 and a beta of 1.13. The company’s 50-day simple moving average is $60.11 and its 200-day simple moving average is $48.50.
Analysts Set New Price Targets
Several brokerages have recently commented on HNGE. Zacks Research upgraded Hinge Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Royal Bank Of Canada raised their price target on Hinge Health from $65.00 to $75.00 and gave the stock an “outperform” rating in a report on Thursday, June 11th. Robert W. Baird boosted their price target on Hinge Health from $55.00 to $65.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 17th. Citigroup restated an “outperform” rating on shares of Hinge Health in a report on Wednesday, May 6th. Finally, Wells Fargo & Company increased their price objective on shares of Hinge Health from $80.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $75.80.
Check Out Our Latest Stock Analysis on HNGE
Hedge Funds Weigh In On Hinge Health
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Marshall Wace LLP acquired a new stake in Hinge Health during the 2nd quarter worth about $367,000. Sei Investments Co. purchased a new position in shares of Hinge Health in the second quarter worth about $869,000. Squarepoint Ops LLC purchased a new position in shares of Hinge Health in the second quarter worth about $19,706,000. Raymond James Financial Inc. acquired a new stake in shares of Hinge Health during the second quarter worth about $3,258,000. Finally, Sandia Investment Management LP acquired a new stake in shares of Hinge Health during the second quarter worth about $657,000.
Hinge Health Company Profile
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Stories
- Five stocks we like better than Hinge Health
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
